These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22344396)

  • 1. Inflammometry: the current state of play.
    Pavord ID; Gibson PG
    Thorax; 2012 Mar; 67(3):191-2. PubMed ID: 22344396
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of sputum eosinophil counts to guide management in children with severe asthma.
    Fleming L; Bush A
    Thorax; 2012 Nov; 67(11):1015-6; author reply 1016. PubMed ID: 22802332
    [No Abstract]   [Full Text] [Related]  

  • 3. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
    Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of sputum eosinophil counts to guide management in children with severe asthma.
    Fleming L; Wilson N; Regamey N; Bush A
    Thorax; 2012 Mar; 67(3):193-8. PubMed ID: 21825081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of mepolizumab on the sputum level of eosinophil-derived protein in three cases of severe asthma.
    Koya T; Kimura Y; Hayashi M; Hasegawa T; Kikuchi T
    Allergol Int; 2020 Oct; 69(4):639-641. PubMed ID: 32439281
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia.
    Laviolette M; Gossage DL; Gauvreau G; Leigh R; Olivenstein R; Katial R; Busse WW; Wenzel S; Wu Y; Datta V; Kolbeck R; Molfino NA
    J Allergy Clin Immunol; 2013 Nov; 132(5):1086-1096.e5. PubMed ID: 23866823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on a therapeutic protocol to improve the control of persistent asthma by monitoring sputum eosinophil counts].
    Cao WL; Sun YC; Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 May; 30(5):334-8. PubMed ID: 17651636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum eosinophil count in athletes with antiasthmatic therapeutic use exemption.
    Lippi G; Banfi G; Guidi GC
    Med Sci Sports Exerc; 2008 Sep; 40(9):1707; author reply 1708. PubMed ID: 19445003
    [No Abstract]   [Full Text] [Related]  

  • 9. An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells.
    Kerr SC; Gonzalez JR; Schanin J; Peters MC; Lambrecht BN; Brock EC; Charbit A; Ansel KM; Youngblood BA; Fahy JV
    Clin Exp Allergy; 2020 Aug; 50(8):904-914. PubMed ID: 32542913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential masking effects of salmeterol on airway inflammation in asthma.
    Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
    Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 2a Study of Benralizumab for Patients with Eosinophilic Asthma in South Korea and Japan.
    Park HS; Kim MK; Imai N; Nakanishi T; Adachi M; Ohta K; Tohda Y;
    Int Arch Allergy Immunol; 2016; 169(3):135-45. PubMed ID: 27097165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).
    Petsky HL; Cates CJ; Lasserson TJ; Li AM; Turner C; Kynaston JA; Chang AB
    Thorax; 2012 Mar; 67(3):199-208. PubMed ID: 20937641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.
    Ciółkowski J; Mazurek H; Hydzik P; Stasiowska B
    Pulm Pharmacol Ther; 2016 Aug; 39():7-13. PubMed ID: 27234706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.
    Turner MO; Johnston PR; Pizzichini E; Pizzichini MM; Hussack PA; Hargreave FE
    Can Respir J; 1998; 5(4):261-8. PubMed ID: 9753527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma control in a random sample of New Zealand adolescent asthmatics.
    van Dalen CJ; Harding E; Parkin J; Blakey K; Cheng S; Pearce NE; Douwes J
    J Asthma; 2007 May; 44(4):261-6. PubMed ID: 17530523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucocorticoids in asthma treatment].
    Uilein S; Köhl N; Müller WE
    Med Monatsschr Pharm; 2001 Dec; 24(12):391-400. PubMed ID: 11793820
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.
    Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE
    Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma.
    Fowler SJ; Tavernier G; Niven R
    J Allergy Clin Immunol; 2015 Mar; 135(3):822-4.e2. PubMed ID: 25445828
    [No Abstract]   [Full Text] [Related]  

  • 19. A sputum gene expression signature predicts oral corticosteroid response in asthma.
    Berthon BS; Gibson PG; Wood LG; MacDonald-Wicks LK; Baines KJ
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28663317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of montelukast on eosinophil apoptosis: induced sputum findings of patients with mild persistent asthma.
    Abadoglu O; Mungan D; Aksu O; Erekul S; Misirligil Z
    Allergol Immunopathol (Madr); 2005; 33(2):105-11. PubMed ID: 15808118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.